Market Research Reports and Industry Reports

Trauma - Pipeline Review, H2 2015

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

Summary
 
 Global Markets Direct’s, ‘Trauma - Pipeline Review, H2 2015’, provides an overview of the Trauma’s therapeutic pipeline.
 
 This report provides comprehensive information on the therapeutic development for Trauma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Trauma and special features on late-stage and discontinued projects.
 
 Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
 
 The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
 
 Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 
 Scope
 
 - The report provides a snapshot of the global therapeutic landscape of Trauma
 - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
 - The report reviews key players involved in the therapeutics development for Trauma and enlists all their major and minor projects
 - The report summarizes all the dormant and discontinued pipeline projects
 - A review of the Trauma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
 - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
 - A detailed assessment of monotherapy and combination therapy pipeline projects
 - Coverage of the Trauma pipeline on the basis of target, MoA, route of administration and molecule type
 - Latest news and deals relating related to pipeline products
 
 Reasons to buy
 
 - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
 - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
 - Develop strategic initiatives by understanding the focus areas of leading companies
 - Identify and understand important and diverse types of therapeutics under development for Trauma
 - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
 - Devise corrective measures for pipeline projects by understanding Trauma pipeline depth and focus of Indication therapeutics
 - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
 - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

 Table of Contents 2
 List of Tables 4
 List of Figures 4
 Introduction 5
 Global Markets Direct Report Coverage 5
 Trauma Overview 6
 Therapeutics Development 7
 Pipeline Products for Trauma - Overview 7
 Pipeline Products for Trauma - Comparative Analysis 8
 Trauma - Therapeutics under Development by Companies 9
 Trauma - Therapeutics under Investigation by Universities/Institutes 10
 Trauma - Pipeline Products Glance 11
 Clinical Stage Products 11
 Early Stage Products 12
 Trauma - Products under Development by Companies 13
 Trauma - Products under Investigation by Universities/Institutes 14
 Trauma - Companies Involved in Therapeutics Development 15
 Bionature E.A. Ltd. 15
 Edge Therapeutics, Inc. 16
 MedImmune, LLC 17
 Trauma - Therapeutics Assessment 18
 Assessment by Monotherapy Products 18
 Assessment by Target 19
 Assessment by Mechanism of Action 21
 Assessment by Route of Administration 23
 Assessment by Molecule Type 24
 Drug Profiles 26
 MEDI-8111 - Drug Profile 26
 Product Description 26
 Mechanism of Action 26
 R&D Progress 26
 nimodipine - Drug Profile 27
 Product Description 27
 Mechanism of Action 27
 R&D Progress 27
 Peptide to Activate GLP1R for CNS, Metabolic Disorders and Head Trauma - Drug Profile 28
 Product Description 28
 Mechanism of Action 28
 R&D Progress 28
 Peptides to Activate GLP-1 Receptor for CNS Disorders and Head Trauma - Drug Profile 30
 Product Description 30
 Mechanism of Action 30
 R&D Progress 30
 PT-00114 - Drug Profile 31
 Product Description 31
 Mechanism of Action 31
 R&D Progress 31
 PT-00311 - Drug Profile 32
 Product Description 32
 Mechanism of Action 32
 R&D Progress 32
 Small Molecules to Agonize Neurotrophin Receptor for CNS and Ophthalmological Disorders - Drug Profile 33
 Product Description 33
 Mechanism of Action 33
 R&D Progress 33
 Synthetic Peptides to Activate SDF-1 Alpha for CNS Disorders and Infectious Disease - Drug Profile 34
 Product Description 34
 Mechanism of Action 34
 R&D Progress 34
 Trauma - Recent Pipeline Updates 35
 Trauma - Dormant Projects 38
 Trauma - Discontinued Products 39
 Trauma - Product Development Milestones 40
 Featured News & Press Releases 40
 Jun 10, 2013: Edge Therapeutics Announces FDA Accepts IND Application For EG-1962 40
 Appendix 41
 Methodology 41
 Coverage 41
 Secondary Research 41
 Primary Research 41
 Expert Panel Validation 41
 Contact Us 41
 Disclaimer 42


List Of Tables

 Number of Products under Development for Trauma, H2 2015 7
 Number of Products under Development for Trauma - Comparative Analysis, H2 2015 8
 Number of Products under Development by Companies, H2 2015 9
 Number of Products under Investigation by Universities/Institutes, H2 2015 10
 Comparative Analysis by Clinical Stage Development, H2 2015 11
 Comparative Analysis by Early Stage Development, H2 2015 12
 Products under Development by Companies, H2 2015 13
 Products under Investigation by Universities/Institutes, H2 2015 14
 Trauma - Pipeline by Bionature E.A. Ltd., H2 2015 15
 Trauma - Pipeline by Edge Therapeutics, Inc., H2 2015 16
 Trauma - Pipeline by MedImmune, LLC, H2 2015 17
 Assessment by Monotherapy Products, H2 2015 18
 Number of Products by Stage and Target, H2 2015 20
 Number of Products by Stage and Mechanism of Action, H2 2015 22
 Number of Products by Stage and Route of Administration, H2 2015 23
 Number of Products by Stage and Molecule Type, H2 2015 25
 Trauma Therapeutics - Recent Pipeline Updates, H2 2015 35
 Trauma - Dormant Projects, H2 2015 38
 Trauma - Discontinued Products, H2 2015 39


List Of Figures

 Number of Products under Development for Trauma, H2 2015 7
 Number of Products under Development for Trauma - Comparative Analysis, H2 2015 8
 Number of Products under Development by Companies, H2 2015 9
 Number of Products under Investigation by Universities/Institutes, H2 2015 10
 Comparative Analysis by Early Stage Products, H2 2015 12
 Assessment by Monotherapy Products, H2 2015 18
 Number of Products by Top 10 Targets, H2 2015 19
 Number of Products by Stage and Top 10 Targets, H2 2015 19
 Number of Products by Top 10 Mechanism of Actions, H2 2015 21
 Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015 21
 Number of Products by Top 10 Molecule Types, H2 2015 24
 Number of Products by Stage and Top 10 Molecule Types, H2 2015 24


Global Trauma Cleaning Machine Market Research Report 2016

Notes:Production, means the output of Trauma Cleaning MachineRevenue, means the sales value of Trauma Cleaning MachineThis report studies Trauma Cleaning Machine in Global market, especially in North America, Europe, China,

USD 2900View Report

United States Trauma Devices Market Report 2016

Notes:Sales, means the sales volume of Trauma DevicesRevenue, means the sales value of Trauma DevicesThis report studies sales (consumption) of Trauma Devices in United States market, focuses on the top

USD 3800View Report

Global Trauma Devices Market Research Report 2016

Notes:Production, means the output of Trauma DevicesRevenue, means the sales value of Trauma DevicesThis report studies Trauma Devices in Global market, especially in North America, Europe, China, Japan, Southeast Asia

USD 2900View Report

Japan Pancreatic Cancer - Pipeline Market Report 2016

Notes:Sales, means the sales volume of Pancreatic Cancer - PipelineRevenue, means the sales value of Pancreatic Cancer - PipelineThis report studies sales (consumption) of Pancreatic Cancer - Pipeline in Japan

USD 3400View Report

Japan Open-Angle Glaucoma - Pipeline Market Report 2016

Notes:Sales, means the sales volume of Open-Angle Glaucoma - PipelineRevenue, means the sales value of Open-Angle Glaucoma - PipelineThis report studies sales (consumption) of Open-Angle Glaucoma - Pipeline in Japan

USD 3400View Report

Global Blepharitis - Pipeline Market Professional Survey Report 2016

Notes:Production, means the output of Blepharitis - PipelineRevenue, means the sales value of Blepharitis - PipelineThis report studies Blepharitis - Pipeline in Global market, especially in North America, Europe, China,

USD 3500View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

Discount on PDF and Enterprise Wide Licence reports
  • PDF $ 2000    $ 2000
  • Site Licence $ 4000    $ 4000
  • Enterprise Wide Licence $ 6000    $ 6000
$ 2000

Reports Details

Published Date : Jul 2015
No. of Pages :42
Country :Global
Category :Healthcare
Publisher :Global Markets Direct
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment